All of the health-care giant's business segments, including its insurer Aetna, its retail pharmacy and health services unit, surpassed expectations.
In this article
CVS Health
on Wednesday blew past first-quarter earnings and revenue estimates and raised its 2026 guidance, as its once-troubled insurance business showed improvement.
CVS, which operates the nation’s largest pharmacy chain, sees full-year profit coming in between $7.30 and $7.50 per share. That’s up from a previous guidance of $7 to $7.20 per share.
The company also expects revenue of at least $405 billion in 2026, up from its prior outlook of at least $400 billion.
The nation's largest private insurer expects 2026 adjusted earnings of more than $18.25 per share, up from a previous outlook of…
Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced scrutiny from regulators and lawmakers…
This backbone of the U.S. health-care industry generates about 99% of its revenue domestically, insulating it from overseas…
Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.
Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.
Shares of Coke have risen just 6% over the last year, hurt by concerns about the broader economy.
